GBT’s Intelligent, Human Vitals qTerm Device Patent Received An Issue Notification

The patent will be granted on May 2, 2023, and protecting AI based sophisticated, electronic health device

GBT Technologies announced that it received a noticed issue and will be granted on May 2, 2023, U.S. patent number 11,638,523, covering its machine learning-driven, human vitals device, non-provisional patent application, qTerm non-provisional patent was filed on August 3, 2020, describing an intelligent, electronic health device to measure human vitals with a touch of a finger, which was assigned qTerm as an internal project name. GBT successfully completed the development of a fully working prototype in 2022 including robust testing, debugging and a participant study. qTerm’s first release measures body temperature, blood oxygen and heart rate vitals. Future releases are planned to include blood pressure measurement and enhanced, AI-driven analytics.

AiThority Interview Insights: AiThority Interview with Brad Anderson, President of Product and Engineering at Qualtrics

The device is accompanied by a smartphone mobile app and synchronized web application to keep measurement history and provide analytics for user’s records at a later phase. The web and mobile applications also enable direct access to user’s data anywhere around the world, enabling efficient, remote telemedicine capabilities. Upon user’s permission, a user’s body temperature and location can be anonymously shared with other users to provide health risk proximity alerts. The patent describes advanced AI technology to perform on-going vitals monitoring and analytics, providing personal health related notifications and alerts. GBT plans to file a continuation patent for qTerm, further strengthening the underlying intellectual property concepts.

Read More about AiThority Interview: AiThority Interview with Ajay Sathyanath, Chief Technology Officer at Madison Logic

GBT Technologies, is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS).

GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services

 Latest AiThority Interview Insights : AiThority Interview with at Brian Sathianathan, Co-Founder and CTO at Iterate.ai

 [To share your insights with us, please write to sghosh@martechseries.com]